Skip to main content

Advertisement

Log in

Impact of adherence to CKD-MBD guidelines on mortality among Japanese dialysis patients: an ecological study

  • Original Article
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Introduction

This study evaluated the association between prefecture-level achievement of chronic kidney disease-mineral and bone disorder (CKD-MBD) parameter targets and mortality in Japanese dialysis patients.

Materials and methods

We conducted an ecological study of all prefectures in Japan using data from the Japanese Society of Dialysis Therapy and National Vital Statistics between 2016 and 2017. We calculated adherence rates to recommend target ranges for CKD-MBD parameters, including phosphate, corrected calcium, and parathyroid hormone (PTH), and explored associations of these rates with prefecture-specific standardized mortality rates (SMRs) among the general population and among prevalent dialysis patients using bivariate association analysis and structural equation modeling.

Results

Prefecture-level adherence to the target phosphate range was significantly and negatively associated with prefecture-specific SMRs in men (standardized estimate (β) = − 0.61, p < 0.001) and women (β = − 0.41, p < 0.001). However, prefecture-level adherence to the target corrected calcium range was significantly and negatively associated with prefecture-specific SMRs only in men (β = − 0.28, p = 0.01). Meanwhile, prefecture-level adherence to the target PTH range was significantly and positively associated with prefecture-specific SMRs in men (β = 0.23, p = 0.04). Prefecture-level SMRs of females in the general population had a significant impact on prefecture-level SMRs of female dialysis patients (β = 0.27, p = 0.03). The models explained 52% of variance in SMR for men and 33% for women.

Conclusion

A higher prefecture-level achievement rate of the target phosphate range recommended by the Japanese CKD-MBD guidelines was associated with a lower prefecture-specific SMR in the Japanese dialysis population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218

    Article  CAS  Google Scholar 

  2. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771–780

    Article  CAS  Google Scholar 

  3. Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 52:519–530

    Article  CAS  Google Scholar 

  4. Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC, Investigators ARO (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 26:1948–1955

    Article  CAS  Google Scholar 

  5. Taniguchi M, Fukagawa M, Fujii N, Hamano T, Shoji T, Yokoyama K, Nakai S, Shigematsu T, Iseki K, Tsubakihara Y, Committee of renal data registry of the Japanese society for dialysis therapy (2013) Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial 17:221–228

    Article  CAS  Google Scholar 

  6. Wakasugi M, Kazama JJ, Wada A, Hamano T, Masakane I, Narita I (2019) Functional impairment attenuates the association between high serum phosphate and mortality in dialysis patients: a nationwide cohort study. Nephrol Dial Transplant 34:1207–1216

    Article  CAS  Google Scholar 

  7. Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int 92:26–36

    Article  Google Scholar 

  8. Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T et al (2013) Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17:247–288

    Article  Google Scholar 

  9. Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M (2004) Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 44:34–38

    Article  Google Scholar 

  10. Fouque D, Roth H, Darné B, Jean-Bouchet L, Daugas E, Drüeke TB, Hannedouche T, Jean G, London GM, Phosphorus F, Observatory C (2018) Achievement of kidney disease: improving global outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the photo-graphe3 study. Clin Kidney J 11:73–79

    Article  CAS  Google Scholar 

  11. Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, Netherlands cooperative study on the adequacy of dialysis (NECOSAD) study group (2005) The kidney disease outcomes quality initiative (K/DOQI) guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis 46:925–932

    Article  Google Scholar 

  12. Palomares I, Ramos R, Martin-Malo A, Merello JI, Praga M, Luño J, de Francisco AL, ORD Group (2013) Compliance with mineral metabolism targets in haemodialysis patients: moving backwards? Blood Purif 36:131

    Article  Google Scholar 

  13. Furumatsu Y, Nagasawa Y, Yamamoto R, Iio K, Iwatani H, Matsui I, Takabatake Y, Kawada N, Shoji T, Imai E, Isaka Y, Rakugi H (2010) Specialist care and improved long-term survival of dialysis patients. Nephrol Dial Transplant 25:1930–1935

    Article  Google Scholar 

  14. Ogata S, Yorioka N (2011) Environmental factors influencing the survival of chronic dialysis patients. Clin Exp Nephrol 15:405–409

    Article  Google Scholar 

  15. Ogata S, Nishi S, Wakai K, Hanafusa N, Iseki K, Tsubakihara Y, Masakane I (2015) Institutional factors influencing regional differences in the 1-year survival of dialysis patients. Hemodial In 19:S5–S10

    Article  Google Scholar 

  16. Wakasugi M, Narita I (2021) Structural equation modeling assessment of the impact of dialysis facility staffing on mortality: an ecological study. Jpn J Nephrol 63:179–186 ((in Japanese))

    Google Scholar 

  17. Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL et al (2006) International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 17:3510–3519

    Article  Google Scholar 

  18. Suzuki E, Kashima S, Kawachi I, Subramanian SV (2012) Geographic inequalities in all-cause mortality in Japan: compositional or contextual? PLoS ONE 7:e39876

    Article  CAS  Google Scholar 

  19. Masakane I, Taniguchi M, Nakai S, Tsuchida K, Wada A, Ogata S, Hasegawa T, Hamano T, Hanafusa N, Hoshino J, Goto S, Yamamoto K, Minakuchi J, Nakamoto H, On behalf of Japanese Society for Dialysis Therapy Renal Data Registry Committee (2018) Annual dialysis data report 2016. JSDT Ren Data Regist Ren Replace Ther 4:45

    Google Scholar 

  20. Nitta K, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Goto S, Wada A, Hamano T, Hoshino J, Joki N, Abe M, Yamamoto K, Nakamoto H, on behalf of Japanese society for dialysis therapy renal data registry committee (2019) Annual dialysis data report 2017. JSDT Ren Data Regist Ren Replace Ther 5:53

    Google Scholar 

  21. Wakasugi M, Narita I (2022) Sex differences in cause-specific mortality in Japanese dialysis patients. Intern Med. https://doi.org/10.2169/internalmedicine.8981-21

    Article  PubMed  Google Scholar 

  22. Wakasugi M, Kawamura K, Yamamoto S, Kazama JJ, Narita I (2012) High mortality rate of infectious diseases in dialysis patients: a comparison with the general population in Japan. Ther Apher Dial 16:226–231

    Article  Google Scholar 

  23. Wakasugi M, Kazama JJ, Yamamoto S, Kawamura K, Narita I (2013) Cause-specific excess mortality among dialysis patients: comparison with the general population in Japan. Ther Apher Dial 17:298–304

    Article  Google Scholar 

  24. Wakasugi M, Matsuo K, Kazama JJ, Narita I (2015) Higher mortality due to intracerebral hemorrhage in dialysis patients: a comparison with the general population in Japan. Ther Apher Dial 19:45–49

    Article  Google Scholar 

  25. Wakasugi M, Kazama JJ, Narita I (2016) Mortality trends among Japanese dialysis patients, 1988–2013: a joinpoint regression analysis. Nephrol Dial Transplant 31:1501–1507

    Article  Google Scholar 

  26. Schober P, Boer C, Schwarte LA (2018) Correlation coefficients: appropriate use and interpretation. Anesth Analg 126:1763–1768

    Article  Google Scholar 

  27. Hooper DCJ, Mullen MR (2008) Equation modelling: guidelines for determining model fit. Electron J Bus Res Methods 6:53–60

    Google Scholar 

  28. Itaya T, Shimizu S, Hara T, Matsuoka Y, Fukuhara S, Yamamoto Y (2021) Association between facility-level adherence to phosphorus management guidelines and mortality in haemodialysis patients: a prospective cohort study. BMJ Open 11:e051002

    Article  Google Scholar 

  29. Kakuta T, Ishida M, Fukagawa M (2018) Critical governance issue of parathyroid hormone assays and its selection in the management of chronic kidney disease mineral and bone disorders. Ther Apher Dial 22:220–228

    Article  Google Scholar 

  30. Hirakata H, Nitta K, Inaba M, Shoji T, Fujii H et al (2012) Japanese society for dialysis therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis. Ther Apher Dial 16:435

    Article  Google Scholar 

  31. Akiba T, Hora K, Imawari M, Sato C, Tanaka E, Izumi N, Harada T, Ando R, Kikuchi K, Tomo T, Hirakata H, Akizawa T (2012) 2011 Japanese society for dialysis therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients. Ther Apher Dial 16:289–310

    Article  CAS  Google Scholar 

  32. Kukita K, Ohira S, Amano I, Naito H, Azuma N, Ikeda K, Kanno Y, Satou T, Sakai S, Sugimoto T, Takemoto Y, Haruguchi H, Minakuchi J, Miyata A, Murotani N, Hirakata H, Tomo T, Akizawa T, Vascular access construction and repair for chronic hemodialysis guideline working group, Japanese society for dialysis therapy (2015) 2011 update Japanese society for dialysis therapy guidelines of vascular access construction and repair for chronic hemodialysis. Ther Apher Dial 19:39

    Article  Google Scholar 

  33. Watanabe Y, Yamagata K, Nishi S, Hirakata H, Hanafusa N et al (2015) Japanese society for dialysis therapy clinical guideline for “hemodialysis initiation for maintenance hemodialysis.” Ther Apher Dial 19:107

    Google Scholar 

  34. Yamamoto H, Nishi S, Tomo T, Masakane I, Saito K, Nangaku M, Hattori M, Suzuki T, Morita S, Ashida A, Ito Y, Kuragano T, Komatsu Y, Sakai K, Tsubakihara Y, Tsuruya K, Hayashi T, Hirakata H (2017) 2015 Japanese society for dialysis therapy: guidelines for renal anemia in chronic kidney disease. Ren Replace Ther 3:36

    Article  Google Scholar 

  35. Isaka Y, Hamano T, Fujii H, Tsujimoto Y, Koiwa F, Sakaguchi Y, Tanaka R, Tomiyama N, Tatsugami F, Teramukai S (2021) Optimal phosphate control related to coronary artery calcification in dialysis patients. J Am Soc Nephrol 32:723–735

    Article  Google Scholar 

Download references

Acknowledgements

We thank the committee of the renal data registry of the Japanese Society for Dialysis Therapy (JSDT) for permission to use their registry data. The results in the current study were derived from split data from the WADDA system of the JSDT by the authors. However, the interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as the official policy or interpretation of the JSDT.

Funding

This work was supported by a research grant from JSPS KAKENHI (Grants-in-Aid for Scientific Research, Grant Number JP18K08202) to MW. No funding agency had any role in the study design, collection, analysis and interpretation of data, writing the report, and the decision to submit the report for publication.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation and data collection and analysis were performed by MW and IN. The first draft of the manuscript was written by MW and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Minako Wakasugi.

Ethics declarations

Conflict of interest

All authors declare that they have no relevant financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wakasugi, M., Narita, I. Impact of adherence to CKD-MBD guidelines on mortality among Japanese dialysis patients: an ecological study. J Bone Miner Metab 40, 810–818 (2022). https://doi.org/10.1007/s00774-022-01351-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-022-01351-5

Keywords

Navigation